NO961274D0 - Azolderivat og farmasöytiske preparat derav - Google Patents

Azolderivat og farmasöytiske preparat derav

Info

Publication number
NO961274D0
NO961274D0 NO961274A NO961274A NO961274D0 NO 961274 D0 NO961274 D0 NO 961274D0 NO 961274 A NO961274 A NO 961274A NO 961274 A NO961274 A NO 961274A NO 961274 D0 NO961274 D0 NO 961274D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
azole derivatives
azole
derivatives
preparations
Prior art date
Application number
NO961274A
Other languages
English (en)
Other versions
NO961274L (no
Inventor
Minoru Okada
Toru Yoden
Eiji Kawaminami
Yoshiaki Shimada
Tsukasa Ishihara
Masafumi Kudou
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO961274L publication Critical patent/NO961274L/no
Publication of NO961274D0 publication Critical patent/NO961274D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961274A 1993-09-30 1996-03-29 Azolderivat og farmasöytiske preparat derav NO961274D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24494493 1993-09-30
PCT/JP1994/001593 WO1995009157A1 (en) 1993-09-30 1994-09-28 Azole derivative and pharmaceutical composition thereof

Publications (2)

Publication Number Publication Date
NO961274L NO961274L (no) 1996-03-29
NO961274D0 true NO961274D0 (no) 1996-03-29

Family

ID=17126291

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961274A NO961274D0 (no) 1993-09-30 1996-03-29 Azolderivat og farmasöytiske preparat derav

Country Status (12)

Country Link
US (1) US5807880A (no)
EP (1) EP0721943A4 (no)
KR (1) KR960704852A (no)
CN (1) CN1131944A (no)
AU (1) AU679119B2 (no)
CA (1) CA2170874A1 (no)
FI (1) FI961418L (no)
HU (1) HUT75871A (no)
NO (1) NO961274D0 (no)
NZ (1) NZ273681A (no)
PL (1) PL313769A1 (no)
WO (1) WO1995009157A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934941A1 (en) 1996-08-09 1999-08-11 Eisai Co., Ltd. Benzopiperidine derivatives
WO1998037070A1 (en) * 1997-02-21 1998-08-27 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
US6559157B2 (en) 1997-10-02 2003-05-06 Daiichi Pharmaceutical Co., Ltd. Dihydronaphthalene compounds
IL133483A0 (en) * 1997-10-02 2001-04-30 Yukijirushi Nyugyo Kabushiki K Novel dihydronaphthalene compounds and processes of producing the same
WO1999054309A1 (en) * 1998-04-23 1999-10-28 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
JP4546589B2 (ja) * 1998-04-23 2010-09-15 武田薬品工業株式会社 ナフタレン誘導体
WO2001030764A1 (en) 1999-10-22 2001-05-03 Takeda Chemical Industries, Ltd. 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
JP4520012B2 (ja) * 1999-10-22 2010-08-04 武田薬品工業株式会社 １−置換−１−（１ｈ−イミダゾール−４−イル）メタノール類
ES2260303T3 (es) 2000-11-17 2006-11-01 Takeda Pharmaceutical Company Limited Derivados de imidazol, metodo para su produccion, y su uso.
WO2002040470A1 (en) 2000-11-20 2002-05-23 Takeda Chemical Industries, Ltd. Imidazole derivatives, process for their preparation and their use
WO2002046186A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
EP1607092A4 (en) * 2003-03-17 2010-12-15 Takeda Pharmaceutical COMPOSITIONS WITH CONTROLLED RELEASE
WO2008021250A2 (en) * 2006-08-10 2008-02-21 Fred Hutchinson Cancer Research Center Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
UY32730A (es) 2009-06-26 2011-01-31 Novartis Ag Inhibidores de cyp17
WO2011041731A2 (en) 2009-10-02 2011-04-07 Fred Hutchinson Cancer Research Center Method of inhibiting bcl-2-related survival proteins
WO2011041737A2 (en) 2009-10-02 2011-04-07 Fred Hutchinson Cancer Research Center Gain-of-function bcl-2 inhibitors
KR101823275B1 (ko) 2010-08-04 2018-03-08 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
US8946260B2 (en) 2010-09-16 2015-02-03 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors
EA201390876A1 (ru) * 2010-12-13 2013-12-30 Вайамет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
AU2012249421B9 (en) 2011-04-28 2015-10-22 Novartis Ag 17alpha-hydroxylase/C17,20-lyase inhibitors
JP5990059B2 (ja) * 2012-08-03 2016-09-07 花王株式会社 ＳｔＡＲ発現抑制剤
JP6275378B2 (ja) * 2012-12-26 2018-02-07 エヌ・イーケムキャット株式会社 カルバゾール類の製造方法およびこの方法により製造されたカルバゾール類。
EP2968219B1 (en) 2013-03-14 2019-04-24 Pellficure Pharmaceuticals, Inc. Novel therapy for prostate carcinoma
EP3191087A1 (en) 2014-09-12 2017-07-19 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
EP3528799A1 (en) 2016-10-24 2019-08-28 Pellficure Pharmaceuticals, Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
WO2019205854A1 (zh) * 2018-04-27 2019-10-31 四川大学 一种10h-吩噻嗪类铁死亡抑制剂及其制备方法与用途
CN109748884B (zh) * 2019-02-19 2022-06-24 成都恒昊创新科技有限公司 一种铁死亡抑制剂及其制备方法与应用
US12448376B2 (en) 2019-11-21 2025-10-21 Chengdu Henghao Innovative Science And Technology Co., Ltd. Phenothiazine ferroptosis inhibitor, preparation method therefor and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
DE3942227A1 (de) * 1989-12-21 1991-06-27 Bayer Ag Triarylmethan-farbbildner
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
WO1995004723A1 (en) * 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Imidazolylalkylamine derivative and pharmaceutical composition thereof

Also Published As

Publication number Publication date
FI961418A0 (fi) 1996-03-29
HUT75871A (en) 1997-05-28
US5807880A (en) 1998-09-15
NO961274L (no) 1996-03-29
KR960704852A (ko) 1996-10-09
HU9600813D0 (en) 1996-05-28
CA2170874A1 (en) 1995-04-06
WO1995009157A1 (en) 1995-04-06
EP0721943A4 (en) 1996-09-04
CN1131944A (zh) 1996-09-25
FI961418A7 (fi) 1996-03-29
AU679119B2 (en) 1997-06-19
NZ273681A (en) 1996-09-25
FI961418L (fi) 1996-03-29
PL313769A1 (en) 1996-07-22
EP0721943A1 (en) 1996-07-17
AU7707194A (en) 1995-04-18

Similar Documents

Publication Publication Date Title
NO961274D0 (no) Azolderivat og farmasöytiske preparat derav
NO306401B1 (no) Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO2009028I1 (no) Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
NO943511L (no) Farmasöytiske preparater og anvendelse derav
NO922506D0 (no) Farmasoeytiske preparat
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
BR1100329A (pt) Composto e formulação farmacêutica
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
NO954146D0 (no) Belagte farmasöytiske preparater
NO984107L (no) Kappa-agonist-forbindelser og farmas°ytiske preparater derav
IS4644A (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
NO960722L (no) Benzazepinderivat, farmasöytisk preparat inneholdende dette, og mellomprodukter for dette
NO180678C (no) N-substituerte heterocykliske forbindelser og farmasöytisk preparat
NO934372D0 (no) Nye forbindelser og farmas!ytisk preparat derav
NO981241D0 (no) Heteroarylsubstituerte akryloylguanidinderivater og farmasöytiske preparater inneholdende disse
NO20006576D0 (no) Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
FI922743L (fi) Preparat
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO973980D0 (no) Imiadazolderivater og medisinsk preparat
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
NO972023D0 (no) Benzisoksasolderivater og pesticidpreparater inneholdende disse
NO304985B1 (no) Bicyklopolyazamakrocyklofosfonsyrer, deres komplekser og farmas°ytisk formulering
NO985572D0 (no) Substituerte amidinobenzenderivater og medisinske preparater derav